AtaiBeckley founder says Eli Lilly’s deal worth up to $3.8 billion has closed
The founder describes the acquisition as the largest transaction in the psychedelic sector’s history and calls Lilly “the best partner we could have wished for.”
TLDR
AtaiBeckley’s founder said on September 11, 2026, that Eli Lilly’s acquisition of the psychedelics biotech company had closed for up to $3.8 billion. In an earlier essay shared on July 16, the founder framed the next phase this way: “Psychedelics needed an evangelist ten years ago. Now it is all about commercialization.”
Combined views
—
1 Source, first seen ago
